Ana Izcue
Overview
Explore the profile of Ana Izcue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seikrit C, Schimpf J, Wied S, Stamellou E, Izcue A, Pabst O, et al.
J Nephrol
. 2022 Sep;
36(2):463-474.
PMID: 36107369
Background: A dysregulated 'gut-kidney axis' may contribute to immunoglobulin A nephropathy (IgAN). We studied whether IgAN patients have disturbed intestinal permeability. Methods: In a prospective, cross sectional, pilot study we...
2.
Pabst O, Izcue A
Nat Rev Gastroenterol Hepatol
. 2021 Dec;
19(3):149-150.
PMID: 34862512
No abstract available.
3.
Llao-Cid L, Roessner P, Chapaprieta V, Ozturk S, Roider T, Bordas M, et al.
Leukemia
. 2021 Mar;
35(11):3152-3162.
PMID: 33731848
Genome-wide association studies identified a single-nucleotide polymorphism (SNP) affecting the transcription factor Eomesodermin (EOMES) associated with a significantly increased risk to develop chronic lymphocytic leukemia (CLL). Epigenetic analyses, RNA sequencing,...
4.
Roessner P, Llao Cid L, Lupar E, Roider T, Bordas M, Schifflers C, et al.
Leukemia
. 2021 Feb;
35(8):2311-2324.
PMID: 33526861
The transcription factor eomesodermin (EOMES) promotes interleukin (IL)-10 expression in CD4 T cells, which has been linked to immunosuppressive and cytotoxic activities. We detected cytotoxic, programmed cell death protein-1 (PD-1)...
5.
Izcue A, Pabst O
Immunity
. 2017 Dec;
47(6):1016-1018.
PMID: 29262344
The gut contents shape intestinal immune homeostasis, a phenomenon best documented for microbiota-immune interactions. In this issue of Immunity, Cao et al. (2017) show that bile acids trigger T cell-mediated...
6.
Meinicke H, Bremser A, Brack M, Schrenk K, Pircher H, Izcue A
Immunology
. 2017 Apr;
152(1):65-73.
PMID: 28437578
Immune homeostasis requires the tight, tissue-specific control of the different CD4 Foxp3 regulatory T (Treg) cell populations. The cadherin-binding inhibitory receptor killer cell lectin-like receptor G1 (KLRG1) is expressed by...
7.
Meinicke H, Bremser A, Brack M, Akeus P, Pearson C, Bullers S, et al.
Immunology
. 2017 Apr;
152(1):74-88.
PMID: 28437001
CD4 Foxp3 regulatory T (Treg) cells include differentiated populations of effector Treg cells characterized by the expression of specific transcription factors. Tumours, including intestinal malignancies, often present with local accumulation...
8.
Rauch K, Hils M, Lupar E, Minguet S, Sigvardsson M, Rottenberg M, et al.
Cell Rep
. 2016 Dec;
17(11):2827-2836.
PMID: 27974197
The transcription factor Foxp3 dominantly controls regulatory T (Treg) cell function, and only its continuous expression guarantees the maintenance of full Treg cell-suppressive capacity. However, transcriptional regulators maintaining Foxp3 transcription...
9.
Pott J, Maloy K, Izcue A
Nat Immunol
. 2016 Mar;
17(4):349-50.
PMID: 27002834
No abstract available.
10.
Lupar E, Brack M, Garnier L, Laffont S, Rauch K, Schachtrup K, et al.
J Immunol
. 2015 Oct;
195(10):4742-52.
PMID: 26453746
CD4(+) T cells polarize into effector Th subsets characterized by signature transcription factors and cytokines. Although T-bet drives Th1 responses and represses the alternative Th2, Th17, and Foxp3(+) regulatory T...